Cyclerion Therapeutics, Inc.
Phosphorus prodrugs of pyrazolo-substituted pyrimidine sGC stimulators
Last updated:
Abstract:
The present patent application discloses the compounds according to Formula (I) shown below, or pharmaceutically acceptable salts thereof wherein J.sup.B, n, R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, m and X as defined herein. ##STR00001##
Status:
Grant
Type:
Utility
Filling date:
6 Jul 2017
Issue date:
23 Feb 2021